Glycopyrrolate Injection
Product Images NDC 0781-3829

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0781-3829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Glycopyrrolate Injection 01)

Chemical structure diagram of glycopyrrolate showing its molecular arrangement, including aromatic rings, hydroxyl group, ester linkage, quaternary ammonium ion, and bromide ion.*

FDA Label Image

Glycopyrrolate-carton-1ml (Glycopyrrolate Injection 02)

Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL by Sandoz Inc. The label indicates it is for intramuscular or intravenous use, contains benzyl alcohol, and comes in 25 single-dose vials of 1 mL each. It is marked for prescription use and not for use in newborns.*

FDA Label Image

Glycopyrrolate-carton-2ml (Glycopyrrolate Injection 03)

Packaging label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) by Sandoz Inc. The label indicates the product is for intramuscular or intravenous use, contains benzyl alcohol, and is not for use in newborns. The box contains 25 single-dose 2 mL vials.*

FDA Label Image

Glycopyrrolate-carton-5ml (Glycopyrrolate Injection 04)

Packaging label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) by Sandoz Inc. The label indicates it is for intramuscular or intravenous use, contains benzyl alcohol, and is packaged as 25 multiple-dose vials of 5 mL each. The label also states it is not for use in newborns.*

FDA Label Image

Glycopyrrolate-carton-20ml (Glycopyrrolate Injection 05)

Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) label for 10 multiple-dose vials. The box indicates the product is for intramuscular or intravenous use, contains benzyl alcohol preservative, and is labeled by Sandoz Inc. Storage and dosage information are included, along with a barcode and distributor details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.